Capital Impact Advisors, LLC Assembly Biosciences, Inc. Transaction History

Capital Impact Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $121,892 - $183,768	-12,400 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$12.9 - $20.8 $728,527 - $1.17 Million	-56,475 Reduced 82.0%	12,400 $1.65 Million
Q4 2018 Mar 08, 2019	BUY	$19.05 - $36.45 $416,947 - $797,781	21,887 Added 46.58%	68,875 $1.52 Million
Q3 2018 Oct 19, 2018	BUY	$34.41 - $44.23 $216,989 - $278,914	6,306 Added 15.5%	46,988 $1.75 Million
Q2 2018 Jul 25, 2018	BUY	$39.21 - $50.29 $345,792 - $443,507	8,819 Added 27.68%	40,682 $1.6 Million
Q1 2018 Apr 11, 2018	BUY	$41.7 - $64.16 $1.33 Million - $2.04 Million	31,863 New	31,863 $1.57 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.